Quality-of-life assessment

In recent years, the value of providing data on the impact of new therapies on health-related quality of life has increasingly been recognized. PAI has extensive experience in all aspects of quality-of-life assessment, including instrument development and validation, study design and administration, data collection and analysis, and report preparation. Recent studies in this area have included patients with type 2 diabetes, advanced prostate cancer, congenital agranulocytosis, and coronary artery disease.